Bitte verwenden Sie diesen Link, um diese Publikation zu zitieren, oder auf sie als Internetquelle zu verweisen: https://hdl.handle.net/10419/278410 
Erscheinungsjahr: 
2023
Schriftenreihe/Nr.: 
Research Paper No. 175
Verlag: 
South Centre, Geneva
Zusammenfassung: 
The purpose of this study is to analyze the compulsory licensing (CL) regimes in selected countries, in particular the economic elements of the granting of Compulsory Licenses (CLs), the determination and negotiation of royalties to the right holder. For this purpose, a descriptive and exploratory analysis of the experiences of granting CLs in selected countries was carried out, focusing on the experiences of developing countries considering their proximity to the Argentine case. In particular, examples of experiences of issuance of CLs or governmental use measures in developing countries are discussed. With a special focus on Latin America, where only two countries have made use of such measures for public health reasons (Ecuador and Brazil). In addition, the effectiveness of the use of CLs or governmental use measures in the reduction of prices is examined, where significant savings are evidenced. In conclusion, the paper proposes the elaboration of a methodology in relation to royalties for Argentina through a payment range that takes into consideration criteria of accessibility and affordability of the licensed technology, as well as the sustainability of the financing agents' budgets.
Schlagwörter: 
Access to Medicines
Argentina
Compulsory Licenses
COVID-19
Doha Declaration on the TRIPS Agreement and Public Health
Flexibilities
Government Use
Health
Intellectual Property
Latin America
Pandemic
Patent
Pharmaceuticals
Public Health
TRIPS
TRIPS Agreement
TRIPS Flexibilities
WTO TRIPS Decision on COVID-19 Vaccines
Dokumentart: 
Research Report
Erscheint in der Sammlung:

Datei(en):
Datei
Größe
5.77 MB





Publikationen in EconStor sind urheberrechtlich geschützt.